ArticleResearch square2026
Whose Truth Is Ground Truth?: Consequences of Label Choice on Machine Learning Models Predicting Depression.
Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Machine learning (ML) models developed using electronic health record (EHR) data frequently rely on provider-documented diagnoses as ground truth to develop models, despite substantial variation in how mental health conditions are diagnosed and recorded. To empirically demonstrate the impact of diagnostic label source, we examined how use of patient-reported, provider-coded, or patient-provider concordant depression labels impact the performance and feature importance of tree-based ML models. We analyzed EHR data from 644,387 adults (2012-2019) in the OCHIN ADVANCE network. Depression outcomes were defined using (1) patient-reported PHQ-9 scores, (2) provider-coded ICD diagnoses, and (3) concordance. Predictors included demographics, vital signs, chronic conditions, and social determinants of health. Classification and regression trees (CART) were trained using 70/30 splits and 10-fold cross-validation. Performance was assessed using sensitivity, specificity, AUC, and F1 score. SHapley Additive exPlanations (SHAP) quantified feature importance. Model performance was modest (AUC = .62-.64); sensitivity was highest for provider-indicated depression (0.33). Feature importance differed substantially by labeling method: anxiety was the only consistently influential predictor across label strategies. Demographic features were highly influential in provider-labeled models but less important in patient-reported or concordant label strategies. We empirically demonstrated how depression label choice alters ML model performance and feature interpretation. Higher AUC values from provider-derived labels were offset by amplified demographic feature importance, raising concerns about the interaction of label choice and bias. Our findings underscore the importance of transparent reporting, comparing labeling strategies, and including patient-reported outcomes in model development to support equitable mental health AI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.